RankAlpha logo
Back to Rankings

PRLD

Prelude TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
Current thesis
The bull case is that PRLD has turned its strategic reset into visible execution: PRT12396 is in Phase 1, PRT13722 remains on track for a mid-2026 IND and 2H 2026 initiation, and cash now extends into Q2 2028 after the May financing [#SEC-8K-2026-05-12] [#10-K-2026-03-10]. That creates multiple shots on goal without a near-term financing spiral.
Posture
Defensive
Lead driver
Momentum
What changed
News driver: Insider Buying : Prelude Therapeutics ( NASDAQ : PRLD ) Director Acquires 2 , 815 , 315 Shares of Stock.
What can break
Coverage is thin; the post-print analyst revisions are informative but not yet a durable validation signal [#PR-EARNINGS-2026-05-16].
Momentum
78
Value
41
Sentiment
31
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.50 · Bull $6.25 · Bear $1.50
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-03 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $8.00
Why
Momentum78 · Δ7d -2.1
Value41 · Δ7d +0.0
Sentiment31 · Δ7d +8.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
78
26% active weight
Current posture
7d trendImproving
Δ7d
-2.1
Δ21d
+14.3
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
31
34% active weight
Current posture
7d trendImproving
Δ7d
+8.7
Δ21d
+2.1
Why this grade

Composite grade D. Momentum 78.5 / Value 41.1 / Sentiment 31.3

Fundamentals (TTM)
As of 2026-07-20
Market Cap
$323.36M
Beta
0.88
Shares Out
79.65M
P/E (TTM) · Derived
-3.1
P/S (TTM)
14.61
P/FCF (TTM) · Derived
-8.29
Rev YoY
+41.0%
EPS YoY
-70.2%
Gross Margin
+90.0%
Op Margin
-1152.8%
Net Debt
-$85.43M
Current Ratio
2.03
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology